Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a maintenance/update to the site's backend or UI. This change does not modify study content or data.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site software release without altering the clinical study information.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check44 days agoChange DetectedUpdated the location entry from Padua, Italy 35128 to Padova, Italy 35128 in the trial locations.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.